Manipal Health Enterprises Limited, the company behind the extensive Manipal Hospitals network, has successfully raised Rs 4,167 crore from anchor investors. This significant capital infusion occurred on July 28, 2026, one day before the opening of its initial public offering (IPO) to the public. The highly anticipated IPO aims to raise a total of Rs 9,275 crore and is set to open for public subscription from July 29 to July 31, 2026.[zerodha+17]
Strong Investor Interest
The anchor book saw strong participation from both global and domestic institutional investors. Prominent international firms that participated included the Abu Dhabi Investment Authority (ADIA), Morgan Stanley Asia, Allianz Global Investors Fund, Natixis International Fund, Societe Generale, and Goldman Sachs Bank Europe.On the domestic front, major mutual fund houses such as ICICI Prudential Mutual Fund, Kotak Mutual Fund, Aditya Birla Sun Life Mutual Fund, UTI Mutual Fund, and HSBC Mutual Fund also invested.Manipal Health Enterprises allotted over 7.06 crore equity shares to these anchor investors at Rs 590 per share. This price was at the upper end of the IPO's price band.[m+5]
The IPO has a price band set between Rs 560 and Rs 590 per equity share, with a face value of Rs 2 each.At the upper end of this price band, the company's market capitalization is estimated to be around Rs 77,600 crore.The public offering consists of a fresh issue of equity shares worth up to Rs 8,000 crore. It also includes an offer for sale (OFS) of up to 2.16 crore equity shares, valued at approximately Rs 1,275.2 crore, by existing shareholders.[zerodha+29]
Strategic Use of Funds
Manipal Health Enterprises plans to use a substantial portion of the fresh issue proceeds for strategic purposes, primarily to strengthen its balance sheet and fund acquisitions. Approximately Rs 5,378 crore to Rs 5,552.8 crore will go towards repaying or prepaying outstanding borrowings and accrued interest of its material subsidiary, Manipal Hospitals Private Limited.This debt reduction is a key objective, reflecting a balance-sheet reset after an aggressive expansion strategy that saw the company's debt increase.[m+7]
Additionally, Rs 574 crore from the fresh issue is earmarked for acquiring a minority stake in Sahyadri Hospitals Private Limited, a step-down subsidiary.The remaining funds from the fresh issue will be allocated for general corporate purposes, supporting the company's ongoing operations and future growth initiatives.[m+14]
Dilip Jose, Managing Director and CEO at Manipal Health Enterprises, stated that the company plans to add an additional 2,426 beds to its existing network by fiscal year 2030. This expansion includes a new 603-bed greenfield hospital in Juhu, Mumbai, and entry into Central India with a 360-bed greenfield hospital in Raipur. He noted that the firm will also add beds to its existing hospitals in Nashik, Pune, Ahilya Nagar, and Bengaluru.[health+1]
Company Background and Market Position
Manipal Health Enterprises, headquartered in Bengaluru, Karnataka, is India's second-largest healthcare provider.The company operates an extensive network of 49 hospitals with 13,037 licensed beds across 14 states and union territories as of March 31, 2026.It boasts the widest footprint among private hospital chains in India.Manipal Hospitals provides a comprehensive range of multi-specialty healthcare services, focusing on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, and organ transplants.[en+14]
The company's history dates back to the Kasturba Medical College, founded in 1953 by T. M. A. Pai.The first Manipal Hospital branch opened in Bangalore in 1991.Over the years, Manipal Health has grown significantly through strategic acquisitions. These include the acquisition of Columbia Asia's 11 hospitals in India for Rs 2,100 crore and Vikram Hospital in Bangalore for Rs 350 crore, both in 2021.In 2023, the company acquired AMRI Hospitals for Rs 2,300 crore and a majority stake in diagnostics firm MedCis PathLabs.More recently, in July 2025, Manipal Health acquired a majority stake in Sahyadri Hospitals for Rs 6,400 crore.[en+9]
Manipal Health Enterprises is backed by prominent investors including Temasek Holdings, through its unit Imperius Healthcare Investments, and TPG.The company's revenue from operations for Fiscal 2026 was reported at Rs 103,357.51 million, or Rs 109,356.18 million on a pro forma basis.[en+12]
IPO Timeline and Listing
The public subscription window for the IPO will remain open until July 31, 2026.The allotment of shares is expected to be finalized on August 3, 2026, with refunds initiated on August 4, 2026.Shares are slated to be credited to demat accounts by August 4, 2026.Manipal Health Enterprises' shares are proposed to be listed on both the BSE and NSE stock exchanges on or about August 5, 2026.[zerodha+31]
The IPO is managed by a consortium of book-running lead managers, including Kotak Mahindra Capital Company, Axis Capital, Goldman Sachs (India) Securities, Jefferies India, J.P. Morgan India, UBS Securities India, and DBS Bank India.This IPO is expected to be one of India's largest healthcare listings in recent years.[smartkarma+9]
